{"filing":{"accession_number":"0001823239-26-000046","cik":"0001823239","ticker":"MRVI","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"mrvi-20260526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323926000046/mrvi-20260526.htm"},"events":[{"id":8270,"run_id":7259,"accession_number":"0001823239-26-000046","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the final voting results from Maravai LifeSciences' 2026 Annual Meeting of Shareholders held on May 26, 2026. The filing presents detailed vote tallies for three proposals: election of three directors (Bernd Brust, Gregory T. Lucier, and Luke Marker), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material shareholder governance event.","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","ticker":"MRVI","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2909,"accession_number":"0001823239-26-000046","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the final voting results from Maravai LifeSciences' 2026 Annual Meeting of Shareholders held on May 26, 2026. The filing presents detailed vote tallies for three proposals: election of three directors (Bernd Brust, Gregory T. Lucier, and Luke Marker), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material shareholder governance event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:41:15.767571+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2909,"accession_number":"0001823239-26-000046","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the final voting results from Maravai LifeSciences' 2026 Annual Meeting of Shareholders held on May 26, 2026. The filing presents detailed vote tallies for three proposals: election of three directors (Bernd Brust, Gregory T. Lucier, and Luke Marker), ratification of Deloitte \u0026 Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material shareholder governance event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:41:15.767571+00:00","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","ticker":"MRVI","filing_date":"2026-05-29"}]}